The point of care diagnostics market share reached USD 30.87 billion in 2023 and is projected to grow at a CAGR of 6.2% from 2023 to 2032, reaching USD 51.19 billion by 2032. This growth highlights significant opportunities in this rapidly expanding, high-volume industry. The report provides a comprehensive analysis of the overall market conditions, trends, regional insights, opportunities, key players, and market segmentation, offering essential information for business success.
Get Your free| Report Sample PDF
The report offers detailed market segmentation, an in-depth assessment of industry leaders, insights into supply chain dynamics and consumer trends, and an exploration of emerging geographical markets. It includes a thorough analysis of significant market developments and competitor landscapes, highlighting key players to equip businesses with comprehensive market and product insights, aiding in the development of effective strategies. The Fortune Business Insights team is committed to understanding clients' businesses and needs, delivering exceptional market research. This meticulously crafted report is designed to meet specific business needs, ensuring its relevance and superior quality.
Reagional analysis:
By Region
- North America (By Product, Sample, End-User, and Country)
- U.S. (By Product)
- Canada (By Product)
- Europe (By Product, Sample, End-User, and Country/Sub-region)
- U.K. (By Product)
- Germany (By Product)
- France (By Product)
- Italy (By Product)
- Spain (By Product)
- Scandinavia (By Product)
- Rest of Europe (By Product)
- Asia Pacific (By Product, Sample, End-User, and Country/Sub-region)
-
- China (By Product)
- Japan (By Product)
- India (By Product)
- Australia (By Product)
- Southeast Asia (By Product)
- Rest of Asia Pacific (By Product)
- Latin America (By Product, Sample, End-User, and Country/Sub-region)
- Brazil (By Product)
- Mexico (By Product)
- Rest of Latin America (By Product)
- Middle East & Africa (By Product, Sample, End-User, and Country/Sub-region)
- GCC (By Product)
- South Africa (By Product)
- Rest of the Middle East & Africa (By Product)
Key Attributes of Point of Care Diagnostics Market:
|
Report Component |
Aspects |
|
Forecast Period |
2024 - 2032 |
|
Projected Market Value (USD) in 2023 |
USD 30.87 billion |
|
Forecasted Market Value (USD) by 2032 |
USD 51.19 billion |
|
Compound Annual Growth Rate |
6.2% |
|
Report Type |
Global |
Our report spans multiple sectors, including pharmaceuticals and medical devices, providing stakeholders with actionable insights to navigate and thrive in this dynamic market. Whether you are a healthcare provider, investor, or policymaker, our research offers crucial knowledge to make informed decisions and foster innovation in the evolving healthcare sector.
Top competitors of the of Point of Care Diagnostics Market:
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Abbott (U.S.)
- EKF Diagnostics Holdings plc (U.K.)
- Cardinal Health, Inc. (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- Quest Diagnostics Incorporated (U.S.)
- BD (U.S.)
- bioMérieux SA (France)
- QuidelOrtho Corporation (U.S.)
- Bio-Rad Laboratories Inc. (U.S.)
Key Industry Developments of Point of Care Diagnostics Market:
-
October 2023: EKF Diagnostics inaugurated a cutting-edge life sciences manufacturing facility in the U.S. to cater to the rising demand from its expanding customer base.
-
March 2023: bioLytical Laboratories Inc. received authorization from Health Canada for its INSTI Multiplex HIV-1/2 Syphilis antibody test, intended for point-of-care settings.
-
February 2023: bioMérieux received U.S. FDA approval for its BIOFIRE SPOTFIRE respiratory panel system, aiming to broaden its point-of-care testing product portfolio.
-
January 2023: Cipla Limited launched Cippoint, a point-of-care device designed for testing non-communicable and infectious diseases, as well as various other health conditions.
-
November 2022: Boditech Med Inc. received approval from the Ministry of Food and Drug Safety (MFDS) for domestic use of the Boditech Quick COVID-19 Ag Saliva test. This advanced home test, which uses a saliva sample, can detect all COVID-19 variants, including Omicron, and provides results within 15 minutes.
Here are several essential elements of point of care diagnostics market 2024-2030 strategy:
To effectively execute a strategy for the point-of-care diagnostics market, businesses should follow a systematic approach. Begin by clearly defining research objectives to outline the necessary questions and information, guiding the research process to ensure data relevance and usefulness. Next, identify the target market through segmentation based on demographics, psychographics, and geographic factors. This segmentation offers vital insights for creating tailored product offerings and developing effective marketing strategies.
Choose a research methodology that aligns with these objectives, using methods like surveys or focus groups to collect accurate data. After gathering data, conduct thorough analysis to uncover trends and insights critical for informed decision-making. Use these insights to draw conclusions and make actionable recommendations, such as adjusting product lines or marketing tactics. Ongoing monitoring and adaptation are essential to remain responsive to changing market conditions, maintaining competitiveness and promoting growth.
Speak|Analyst for Queries
The point of care diagnostics market report equips investors with vital tools to enhance decision-making, explore a wide range of investment opportunities, and effectively pursue their financial objectives. Moreover, the point of care diagnostics market industry is experiencing rapid growth, propelled by factors detailed in the report, with significant expansion anticipated in the forecast period.
Table of Content :
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- Key Industry Developments - Merger, Acquisitions, and Partnerships
- Porter’s Five Forces Analysis
- SWOT Analysis
- Technological Developments
- Value Chain Analysis
TOC Continued…!
Quick Buy - Point of Care Diagnostics Market Report: https://www.fortunebusinessinsights.com/checkout-page/101072
Advanced Glycation End Products Inhibitors Market 2024 Key Drivers, Industry share & Trends and Forecasts to 2032
Advanced Glycation End Products Inhibitors Market 2024 Data Current and Future Trends, Revenue, Business Growth Forecast to 2032
Advanced Glycation End Products Inhibitors Market 2024 Latest Industry share, Growth, Demand, Trends Forecasts to 2032
Advanced Glycation End Products Inhibitors Market 2024 share, Trends Outlook, Geographical Segmentation Forecasts to 2032
Advanced Glycation End Products Inhibitors Market 2024 share, Gross Margin, Trends, Future Demand, Analysis by Top Leading Players and Forecast till 2032
Comments
0 comment